# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed Sep 3, 2019

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2019-09-03
- Accepted by EDGAR: Sep 3, 2019, 12:49 ET
- Period: 2019-08-30
- Accession: 0000875320-19-000043
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000087532019000043/a8-kaug2019semma.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000087532019000043/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000087532019000043/a8-kaug2019semma.htm

Filed Sep 3, 2019.
Source: SEC EDGAR, the filing index for accession 0000875320-19-000043. Last ingested by Listed: Nov 6, 2026, 12:56 ET. No prices; not investment advice.
